Biosidus - Ownership and Business Overview

Life ScienceCompany

Biosidus Ownership

Who owns Biosidus?

Biosidus is owned by ACON Investments and Humus Capital Partners. It was acquired on June 7, 2018.

Is Biosidus PE-backed?

Yes. Biosidus is owned by private equity investors ACON Investments and Humus Capital Partners.

Biosidus Business Overview

Where is Biosidus headquartered?

Biosidus is headquartered in Buenos Aires, Argentina.

What sector is Biosidus in?

Biosidus is a life science company.

When was Biosidus founded?

Biosidus was founded in 1983.

Life Science M&A Summary in 2018

Out of 60 sectors in the Mergr database, life science ranked 7 in number of deals in 2018. The largest life science acquisition in 2018 was Shire - which was acquired by Takeda Pharmaceutical for $67.7B.

Join Mergr to view all 247 acquisitions of life science companies in 2018, including 44 acquisitions by private equity firms, and 203 by strategics.

Biosidus

Biosidus S.A.

Constitución 4234,
Buenos Aires, C1254ABX
Argentina,
+5411 4909 8000
www.biosidus.com.ar

Biosidus is a manufacturer and distributor of biosimilar pharmaceuticals with exports worldwide to more than 25 countries across four continents. The Company's efforts are mainly focused on accelerating the arrival to the market of our pipeline as well as developing innovative technologies such as gene therapy applied to vascular pathology at the central or peripheral level and Transgenic Animals, a technological platform applied to human proteins and functional foods. Biosidus was founded in 1983 and is based in Buenos Aires, Argentina.


 Subscribe to unlock this and 208,055
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 201K M&A Transactions
  • 203K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 81K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.

Related Lists for Biosidus

Life Science Companies , Argentina Companies